e-learning
resources
Amsterdam 2015
Tuesday, 29.09.2015
TB treatment: new drugs and drug resistance
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Efficacy of treatment of MDR/XDR TB patients with diabetes mellitus
Irina Vasilyeva Anatolievna (Moscow, Russian Federation), Irina Vasilyeva, Anastasia Samoilova, Svetlana Moiseeva, Natalia Kuzmina, Natalia Musatova
Source:
International Congress 2015 – TB treatment: new drugs and drug resistance
Session:
TB treatment: new drugs and drug resistance
Session type:
Poster Discussion
Number:
3338
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Irina Vasilyeva Anatolievna (Moscow, Russian Federation), Irina Vasilyeva, Anastasia Samoilova, Svetlana Moiseeva, Natalia Kuzmina, Natalia Musatova. Efficacy of treatment of MDR/XDR TB patients with diabetes mellitus. Eur Respir J 2015; 46: Suppl. 59, 3338
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Clinical manifestations and efficacy MDR/XDR tuberculosis in patients with different type’s of diabetes mellitus
Source: International Congress 2015 – Case series and clinical conundrums in TB
Year: 2015
Impact of diabetes mellitus on drug-resistant tuberculosis treatment outcomes in Georgia – Cohort study
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013
Effectiveness of lung surgery in MDR TB patients with diabetes mellitus
Source: International Congress 2016 – Open problems in thoracic surgery
Year: 2016
Impact of diabetes mellitus on clinical parameters and treatment outcomes of diagnosed pulmonary tuberculosis patients
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1
Year: 2014
Plasma concentration of isoniazid and rifampin in new tuberculosis patients with and without diabetes mellitus
Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes
Year: 2015
Effect of diabetes mellitus on the Time of mycobacterial clearance from sputum during the treatment of multi-drugs resistant tuberculosis
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2
Year: 2014
Addressing the tuberculosis (TB) and diabetes mellitus (DM) co-epidemic among TB patients in Luanda, Angola
Source: International Congress 2016 – Epidemiological aspects of tuberculosis and other respiratory conditions: from lung cancer to late-onset Pompe's disease
Year: 2016
Impact of diabetes mellitus on treatment outcomes of patients with active tuberculosis in an endemic area
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management II
Year: 2013
Tuberculosis and diabetes mellitus: Treatment outcomes using directly observed therapy (DOT)
Source: International Congress 2015 – Management of TB: a patient focus
Year: 2015
Comparison of the clinical manifestations of tuberculosis in patients with different type’s of diabetes mellitus and without it
Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe
Year: 2016
Factors associated with severity of pulmonary tuberculosis and mortality in TB patients with diabetes mellitus
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1
Year: 2014
Tuberculosis with diabetes mellitus: Does delayed sputum conversion always needs MDR evaluation?
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1
Year: 2014
Clinical experience of clofazimine in the treatment of MDR-TB
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013
MDR-TB treatment outcomes in HIV positive patients
Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention
Year: 2014
Outcomes among patients with pulmonary TB with diabetes mellitus treated with anti-TB drugs of 1
st
line
Source: Annual Congress 2010 - Adverse events of antituberculosis treatment and comorbidities
Year: 2010
Could side effects of MDR-TB treatment change the outcome of the disease?
Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes
Year: 2015
Screening of diabetes mellitus among new cases of tuberculosis
Source: Annual Congress 2013 –Diagnostic features of tuberculosis I
Year: 2013
Treatment interruptions in patients with MDR/XDR-TB: risk factors and impact on treatment outcomes
Source: International Congress 2016 – Drug-resistant tuberculosis and experiences with delamanid and bedaquiline
Year: 2016
Failure predictors when treating MDR-TB
Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes
Year: 2015
Healing predictors when treating MDR-TB
Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept